Abstract

In a recent article in The Journal of the American Medical Association , Lichtenberg, Werner and Lueck 1 questioned both the pathogenicity of the fusospirochetal organisms and the success of treatment with the arsenicals. After a number of years of experience with the disease in the laboratory and in the clinic, I have arrived at the conclusion diametrically opposed to that of Lichtenberg and his associates, that this group of anaerobic organisms has under certain conditions a primary pathogenicity, and that arsenical therapy is usually the most efficient treatment. In view of this difference of opinion, it seems advisable to review the evidence in favor of the pathogenicity of this group of organisms and to report some cases which illustrate the indications, dangers and limitations of arsenical therapy in fusospirochetal infections. In 1894, Veillon 2 observed in necrotic, foul lesions of the throat the following mixture of

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.